The organization's CEO, David Hankin, immediately lauded the ruling, adding that the Foundation now plans to launch trials of MMN systems on humans, in the hopes of receiving clearance from the FDA. "The FCC's decision removes the most significant roadblock to helping people, " Hankin said.
ENGADGET: FCC grants radio spectrum to muscle-stimulating wireless devices for paralysis patients